EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrated scRNA ‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer

Yuan-Jie Liu iD, Qian-Wen Ye, Hui Zhang, Ning Yang, Yang Li iD, Jie-Pin Li iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.72369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yuan-Jie Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangs…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cancer-Associated Fibroblasts, Biomarkers, Tumor, Glypicans. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Postdoctoral Science Foundation, Special Support program of China Postdoctoral Science Foundation, Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spatial heterogeneity in the colorectal cancer (CRC) tumor microenvironment (TME) is closely related to stromal organization and may influence treatment‐related features. In this study, we integrated single‐cell RNA sequencing and spatial transcriptomic data from CRC tissues to examine cancer‐associated fibroblast (CAF)‐dominant spatial domains. GPC1 and CHPF were enriched in stromal regions and showed higher expression in CRC tissues than in normal tissues. In the analyzed cohorts, higher GPC1 and CHPF expression was associated with advanced clinicopathological features and poorer survival outcomes in univariate analyses. Single‐cell analyses showed that GPC1 and CHPF were mainly expressed in fibroblasts and were enriched in an ADAM12‐associated fibroblast subset with myofibroblast‐like features, extracellular matrix‐related genes, and hypoxia/glycolysis‐related signatures. Cell–cell communication analysis suggested that this fibroblast subset was linked to higher inferred WNT signaling. Drug‐response and immunotherapy‐related analyses further showed that GPC1 and CHPF expression was associated with transcriptomic patterns related to treatment response. In mucinous adenocarcinoma (MA), the ADAM12‐associated fibroblast program showed stronger inferred MIF‐related signaling and was associated with macrophage M2‐like features. Spatial mapping and multiplex immunofluorescence supported partial colocalization of GPC1, CHPF, and ADAM12 in CAF‐rich stromal regions. In CAFs, GPC1 or CHPF knockdown reduced ADAM12, CAF activation markers, and WNT/MIF‐related proteins, while ADAM12 knockdown weakened macrophage M2‐like marker expression in a co‐culture model. These findings suggest that GPC1 and CHPF mark an ADAM12‐associated CAF program linked to stromal remodeling and immune‐related features in CRC, especially in MA, but further studies are needed to define its functional role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCancer-Associated FibroblastsBiomarkers, TumorGlypicansHumansTumor MicroenvironmentSpatial TranscriptomicsGene Expression Regulation, NeoplasticADAM12 ProteinSingle-Cell Gene Expression AnalysisRNA-SeqMaleFemale

Stichwörter der Autor:innen

ADAM12CHPFGPC1cancer‐associated fibroblastscolorectal cancerimmunotherapyspatial domains

Substanzen

Biomarkers, TumorGlypicansADAM12 ProteinADAM12 protein, human

Autor:innen und Institutionen

  • Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Oncology, Jiangxi Province Hospital of Chinese Medicine, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
  • Shanghai Seventh People's Hospital, Shanghai University of Chinese Medicine, Shanghai, China.
  • Department of Endoscopy Center, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Jiangsu Provincial Key Laboratory of Tumor Systems Biology and Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Yuan-Jie Liu, Yang Li, Jie-Pin Li

Förderung

  • China Postdoctoral Science Foundation
  • Special Support program of China Postdoctoral Science Foundation
  • Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • Projects of Chinese Medicine and integrated Chinese and Western medicine in Jiangsu Province, China

Zitieren

APA

Liu, Y. J., Ye, Q. W., Zhang, H., Yang, N., Li, Y., & Li, J. P. (2026). Integrated scRNA ‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72369

Vancouver

Liu YJ, Ye QW, Zhang H, Yang N, Li Y, Li JP. Integrated scRNA ‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer. Cancer Medicine. 2026. doi:10.1002/cam4.72369

BibTeX
@article{Liu2026,
  author = {Liu, Yuan-Jie and Ye, Qian-Wen and Zhang, Hui and Yang, Ning and Li, Yang and Li, Jie-Pin},
  title = {Integrated scRNA ‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72369}
}
Kostenlos starten →